Stephens Investment Management Group LLC Acquires 3,372 Shares of Azenta, Inc. $AZTA

Stephens Investment Management Group LLC grew its holdings in Azenta, Inc. (NASDAQ:AZTA) by 0.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 807,173 shares of the company’s stock after purchasing an additional 3,372 shares during the period. Stephens Investment Management Group LLC owned approximately 1.76% of Azenta worth $24,845,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Dynamic Technology Lab Private Ltd bought a new stake in Azenta during the 1st quarter worth approximately $505,000. Exchange Traded Concepts LLC increased its holdings in Azenta by 44.2% during the 2nd quarter. Exchange Traded Concepts LLC now owns 417,597 shares of the company’s stock worth $12,854,000 after acquiring an additional 128,084 shares during the period. Kera Capital Partners Inc. bought a new stake in Azenta during the 2nd quarter worth approximately $321,000. Caxton Associates LLP bought a new stake in Azenta during the 1st quarter worth approximately $1,347,000. Finally, Nordea Investment Management AB increased its holdings in Azenta by 31.7% during the 2nd quarter. Nordea Investment Management AB now owns 149,200 shares of the company’s stock worth $4,566,000 after acquiring an additional 35,874 shares during the period. Institutional investors own 99.08% of the company’s stock.

Azenta Stock Performance

Shares of Azenta stock opened at $31.71 on Thursday. Azenta, Inc. has a 52-week low of $23.91 and a 52-week high of $55.63. The stock has a market capitalization of $1.45 billion, a price-to-earnings ratio of -13.10 and a beta of 1.62. The company has a fifty day moving average of $30.50 and a 200-day moving average of $29.66.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.06. The business had revenue of $143.94 million during the quarter, compared to analysts’ expectations of $149.64 million. Azenta had a negative net margin of 18.45% and a positive return on equity of 1.35%. The firm’s revenue for the quarter was up .0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.14 EPS. On average, equities research analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have commented on AZTA shares. Stephens started coverage on shares of Azenta in a research note on Tuesday, July 22nd. They issued an “equal weight” rating and a $35.00 price target for the company. Raymond James Financial raised shares of Azenta from a “market perform” rating to an “outperform” rating and set a $35.00 price target for the company in a research note on Wednesday, August 6th. Weiss Ratings reissued a “sell (d-)” rating on shares of Azenta in a research note on Wednesday, October 8th. Finally, Evercore ISI set a $33.00 price target on shares of Azenta and gave the stock an “in-line” rating in a research note on Tuesday, August 5th. Two research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $35.75.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.